WIA
CBAY

Wetzel Investment Advisors’s Cymabay Therapeutics CBAY Stock Holding History

Wetzel Investment Advisors’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,000
Closed -$71K – 1101
2023
Q4 		$71K Buy
+3,000
New +$53.4K 0.04% 213

Other funds holding CBAY

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Wetzel Investment Advisors's CBAY Position: Q1 2024 in Review

Wetzel Investment Advisors sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 3,000 shares — an estimated $71K sold.

Wetzel Investment Advisors first reported a position in CBAY in Q4 2023 and held it in 1 quarter. The position peaked at $71K in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

  • Wetzel Investment Advisors reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Wetzel Investment Advisors sold 3,000 Cymabay Therapeutics shares in Q1 2024, an estimated $71K.
  • Wetzel Investment Advisors first reported a position in Cymabay Therapeutics in Q4 2023 and held it in 1 quarter.
  • Wetzel Investment Advisors's Cymabay Therapeutics position peaked at $71K in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Wetzel Investment Advisors's 13F filing for Q1 2024, filed 23 Apr 2024.